|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Fosinopril#Adult Indications and Dosage]] |
| {{Fosinopril}}
| |
| {{CMG}}; {{AE}} {{AM}}
| |
| | |
| ==Indications and Usage==
| |
| | |
| Fosinopril Na tablets (fosinopril sodium tablets) are indicated for the treatment of [[hypertension]]. They may be used alone or in combination with [[thiazide diuretics]].
| |
| | |
| Fosinopril Na tablets are indicated in the management of [[heart failure]] as adjunctive therapy when added to conventional therapy including diuretics with or without [[digitalis]].
| |
| | |
| In using fosinopril Na tablets consideration should be given to the fact that another angiotensin converting enzyme inhibitor, [[captopril]], has caused [[agranulocytosis]], particularly in patients with renal impairment or collagen-vascular disease. Available data are insufficient to show that fosinopril does not have a similar risk (see WARNINGS).
| |
| | |
| In considering use of fosinopril Na tablets, it should be noted that in controlled trials ACE inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. In addition, ACE inhibitors (for which adequate data are available) cause a higher rate of [[angioedema]] in black than in non-black patients.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FOSINOPRIL NA (FOSINOPRIL SODIUM) TABLET [APOTEX CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eaa753e8-9fda-af0b-9d54-bdf0d1674832 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |